Abstract

Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study
Claire Castagné ... Claire Gallois
Clinical Colorectal Cancer | VOL. 22
Claire Castagné, et. al.Claire Castagné ... Claire Gallois
24 Dec 2022
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience
...
ESMO Open | VOL. 7
, et. al. ...
01 Jun 2022
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial
Marine Sivignon ... Emmanuelle Samalin
BMJ Open | VOL. 12
Marine Sivignon, et. al.Marine Sivignon ... Emmanuelle Samalin
01 Nov 2022
P-7 Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal cancer: Update on the first real-world study in Germany and Austria – BERING CRC
H Müller-Huesmann ... B Schmidt
Annals of Oncology | VOL. 33
H Müller-Huesmann, et. al.H Müller-Huesmann ... B Schmidt
01 Jun 2022
View more papers

More From: Oncology in Clinical Practice

Paper Title
Journal
Date
Author
An early diagnosed medulloblastoma of the vermis
Mansour Parvaresh ... Alireza Sadeghipour
Oncology in Clinical Practice | VOL. -
Mansour Parvaresh, et. al.Mansour Parvaresh ... Alireza Sadeghipour
24 Apr 2024
Cardiac metastasis of lung cancer diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)
Abderrahim Doudouh ... Salah Nabih Oueriagli
Oncology in Clinical Practice | VOL. 20
Abderrahim Doudouh, et. al.Abderrahim Doudouh ... Salah Nabih Oueriagli
23 Apr 2024
Immunochemotherapy in a 25-year-old male patient with small-cell lung cancer
Renata Langfort ... Krawczyk Paweł
Oncology in Clinical Practice | VOL. 20
Renata Langfort, et. al.Renata Langfort ... Krawczyk Paweł
23 Apr 2024
The effect of different concentrations of anti-PD-1 and anti-PD-L1 antibodies on the activity of immune system cells in patients with non-small cell lung cancer
Aleksandra Bożyk ... Marcin Nicoś
Oncology in Clinical Practice | VOL. 20
Aleksandra Bożyk, et. al.Aleksandra Bożyk ... Marcin Nicoś
23 Apr 2024
View more papers